<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>ABSTRACT Our group has previously demonstrated that expression of the cytokine SCF by leukemic blasts is a frequent finding in pre-B <z:hpo ids='HP_0006721'>acute lymphoblastic leukemia</z:hpo> (ALL) </plain></SENT>
<SENT sid="1" pm="."><plain>Whether SCF expression is a feature of other B cell <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> and whether cross talk from the local microenvironment modulates malignant cell SCF production is, however, unknown </plain></SENT>
<SENT sid="2" pm="."><plain>Here we show using immunohistochemistry that SCF is expressed by a wide variety of indolent and aggressive B cell <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> involving the bone marrow (BM) or lymph nodes (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LNs</z:e>) </plain></SENT>
<SENT sid="3" pm="."><plain>In diseases such as follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (FL), however, where <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cells uniquely associate with the BM endosteal niche, BM <z:hpo ids='HP_0002665'>lymphoma</z:hpo> does not express SCF, while <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LN</z:e> involvement is SCF positive </plain></SENT>
<SENT sid="4" pm="."><plain>In contrast, FL cases with high-grade transformation in the BM are SCF positive </plain></SENT>
<SENT sid="5" pm="."><plain>These data suggest that <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cell interaction with the endosteal niche inhibits SCF production, and that FL cells become independent of this microenvironment effect following transformation </plain></SENT>
</text></document>